GlassScriptPhysician profile
Paul E Jennings
NPI 1205985942
$5,151.93
in general payments reported to CMS, 2019-2025
12 companies · $301 in 2025
The $301 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.59 · 2020: $17.40 · 2021: $196 · 2022: $4,219 · 2023: $367 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $668.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $668.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $3,600.00 | 2022 | |
| Stryker Corporation | $494.92 | 2021-2022 | |
| Medtronic, INC. | $192.37 | 2023 | Signia |
| Silk Road Medical, INC. | $174.89 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Abbott Laboratories | $156.06 | 2025 | Proclaim |
| Bolton Medical INC | $144.90 | 2025 | Gelweave, Relay Thoracic Stent-Graft With Plus Delivery System |
| Boston Scientific Corporation | $131.42 | 2022 | |
| Axonics, INC. | $80.17 | 2021 | |
| Ctl Medical Corporation | $61.15 | 2022 | |
| Merck Sharp & Dohme LLC | $51.59 | 2019 | |
| Foundation Fusion Solutions, LLC | $47.06 | 2022 | |
| Si-Bone, INC. | $17.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Jennings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.